Alector, Inc. - stock earnings
ALEC Upcoming estimated earnings
Date | Actual / Estimated EPS | Low Revenue | Actual / Estimated Revenue | High Revenue |
---|---|---|---|---|
May 2, 2024 AfterMarket | -0.49 / -0.52 | - | - / 15.1 million | - |
ALEC Quarterly earnings
Date | Earnings | Revenue |
---|---|---|
2023Q4 | -41.4 million USD | 15.2 million USD |
2023Q3 | -44.5 million USD | 9.1 million USD |
2023Q2 | 1.4 million USD | 56.2 million USD |
2023Q1 | -45.9 million USD | 16.5 million USD |
2022Q4 | -52.4 million USD | 14.4 million USD |
2022Q3 | -46.1 million USD | 14.9 million USD |
2022Q2 | 9.9 million USD | 79.9 million USD |
2022Q1 | -44.6 million USD | 24.5 million USD |
2021Q4 | -55.6 million USD | 14.0 million USD |
2021Q3 | 126.6 million USD | 182.4 million USD |
2021Q2 | -55.1 million USD | 6.6 million USD |
2021Q1 | -52.2 million USD | 4.1 million USD |
2020Q4 | -52.2 million USD | 4.9 million USD |
2020Q3 | -52.7 million USD | 5.9 million USD |
2020Q2 | -45.3 million USD | 3.2 million USD |
2020Q1 | -40.0 million USD | 7.2 million USD |
2019Q4 | -30.5 million USD | 6.0 million USD |
2019Q3 | -31.7 million USD | 2.7 million USD |
2019Q2 | -24.6 million USD | 6.9 million USD |
2019Q1 | -18.6 million USD | 5.6 million USD |
2018Q4 | -17.4 million USD | 9.1 million USD |
2018Q3 | -15.3 million USD | 6.5 million USD |
2018Q2 | -11.1 million USD | 7.1 million USD |
2018Q1 | -8.4 million USD | 4.9 million USD |
2017Q4 | -9.8 million USD | 3.1 million USD |
2016Q4 | ? USD | 416000 USD |
ALEC Yearly earnings
Date | Earnings | Revenue |
---|---|---|
2023 | -130.4 million USD | 97.1 million USD |
2022 | -133.3 million USD | 133.6 million USD |
2021 | -28.0 million USD | 207.1 million USD |
2020 | -183.0 million USD | 21.1 million USD |
2019 | -99.8 million USD | 21.2 million USD |
2018 | -52.2 million USD | 27.7 million USD |
2017 | -32.5 million USD | 3.7 million USD |
2016 | -15.1 million USD | 416000 USD |
ALEC
Price: $5.39
52 week price:
Earnings Per Share: -1.56 USD
P/E Ratio: -3.41
Exchange: NMS
Sector: Healthcare
Industry: Biotechnology
Volume: 209662
Market Capitalization: 519.5 million